Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 19, 2018 - Issue 11
Submit an article Journal homepage
348
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary disease

Dave SinghUniversity of Manchester, Medicines Evaluation Unit, The Langley Building, Manchester University NHS Foundation Hospital Trust, Manchester, UKCorrespondence[email protected]
View further author information
Pages 1279-1287 | Received 30 Mar 2018, Accepted 06 Jul 2018, Published online: 13 Aug 2018

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Luca Richeldi, Alessio Piraino, Francesco Macagno, Gianluigi Micarelli & Eleonora Ingrassia. (2021) The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study Protocol. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 159-166.
Read now

Articles from other publishers (3)

Emanuela Resta, Giulia Scioscia, Donato Lacedonia, Carla Maria Irene Quarato, Francesco Panza, Onofrio Resta, Giorgia Lepore, Enrico Buonamico, Valentina Di Lecce, Giovanna Elisiana Carpagnano, Maria Pia Foschino Barbaro & Noemi Rossi. (2022) Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region. BMC Health Services Research 22:1.
Crossref
Sergey N. Avdeev & Natal’ya V. Trushenko. (2019) Triple therapy in chronic obstructive pulmonary disease. Russian Pulmonology 29:2, pages 199-206.
Crossref
Lowie E.G.W. Vanfleteren, Anders Ullman, Anita Nordenson, Anders Andersson, Kristina Andelid & Leonardo M. Fabbri. (2019) Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box. ERJ Open Research 5:1, pages 00185-2018.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.